134 related articles for article (PubMed ID: 32005583)
1. Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study.
Cabasag CJ; Butler J; Arnold M; Rutherford M; Bardot A; Ferlay J; Morgan E; Møller B; Gavin A; Norell CH; Harrison S; Saint-Jacques N; Eden M; Rous B; Nordin A; Hanna L; Kwon J; Cohen PA; Altman AD; Shack L; Kozie S; Engholm G; De P; Sykes P; Porter G; Ferguson S; Walsh P; Trevithick R; Tervonen H; O'Connell D; Bray F; Soerjomataram I
Gynecol Oncol; 2020 Apr; 157(1):234-244. PubMed ID: 32005583
[TBL] [Abstract][Full Text] [Related]
2. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.
Arnold M; Rutherford MJ; Bardot A; Ferlay J; Andersson TM; Myklebust TÅ; Tervonen H; Thursfield V; Ransom D; Shack L; Woods RR; Turner D; Leonfellner S; Ryan S; Saint-Jacques N; De P; McClure C; Ramanakumar AV; Stuart-Panko H; Engholm G; Walsh PM; Jackson C; Vernon S; Morgan E; Gavin A; Morrison DS; Huws DW; Porter G; Butler J; Bryant H; Currow DC; Hiom S; Parkin DM; Sasieni P; Lambert PC; Møller B; Soerjomataram I; Bray F
Lancet Oncol; 2019 Nov; 20(11):1493-1505. PubMed ID: 31521509
[TBL] [Abstract][Full Text] [Related]
3. Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project).
Araghi M; Arnold M; Rutherford MJ; Guren MG; Cabasag CJ; Bardot A; Ferlay J; Tervonen H; Shack L; Woods RR; Saint-Jacques N; De P; McClure C; Engholm G; Gavin AT; Morgan E; Walsh PM; Jackson C; Porter G; Møller B; Bucher O; Eden M; O'Connell DL; Bray F; Soerjomataram I
Gut; 2021 Jan; 70(1):114-126. PubMed ID: 32482683
[TBL] [Abstract][Full Text] [Related]
4. Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study.
Pilleron S; Charvat H; Araghi M; Arnold M; Fidler-Benaoudia MM; Bardot A; Grønlie Guren M; Tervonen H; Little A; O'Connell DL; Gavin A; De P; Aagard Thomsen L; Møller B; Jackson C; Bucher O; Walsh PM; Vernon S; Bray F; Soerjomataram I
Int J Cancer; 2021 Apr; 148(7):1575-1585. PubMed ID: 33006395
[TBL] [Abstract][Full Text] [Related]
5. Comparison of liver cancer incidence and survival by subtypes across seven high-income countries.
Rutherford MJ; Arnold M; Bardot A; Ferlay J; De P; Tervonen H; Little A; Bucher O; St Jacques N; Gavin A; Engholm G; Møller B; O'Connell DL; Merrett N; Parkin DM; Bray F; Soerjomataram I
Int J Cancer; 2021 Dec; 149(12):2020-2031. PubMed ID: 34460109
[TBL] [Abstract][Full Text] [Related]
6. Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership.
Maringe C; Walters S; Butler J; Coleman MP; Hacker N; Hanna L; Mosgaard BJ; Nordin A; Rosen B; Engholm G; Gjerstorff ML; Hatcher J; Johannesen TB; McGahan CE; Meechan D; Middleton R; Tracey E; Turner D; Richards MA; Rachet B;
Gynecol Oncol; 2012 Oct; 127(1):75-82. PubMed ID: 22750127
[TBL] [Abstract][Full Text] [Related]
7. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.
Coleman MP; Forman D; Bryant H; Butler J; Rachet B; Maringe C; Nur U; Tracey E; Coory M; Hatcher J; McGahan CE; Turner D; Marrett L; Gjerstorff ML; Johannesen TB; Adolfsson J; Lambe M; Lawrence G; Meechan D; Morris EJ; Middleton R; Steward J; Richards MA;
Lancet; 2011 Jan; 377(9760):127-38. PubMed ID: 21183212
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic cancer survival by stage and age in seven high-income countries (ICBP SURVMARK-2): a population-based study.
Cabasag CJ; Arnold M; Rutherford M; Bardot A; Ferlay J; Morgan E; Little A; De P; Dixon E; Woods RR; Saint-Jacques N; Evans S; Engholm G; Elwood M; Merrett N; Ransom D; O'Connell DL; Bray F; Soerjomataram I
Br J Cancer; 2022 Jun; 126(12):1774-1782. PubMed ID: 35236937
[TBL] [Abstract][Full Text] [Related]
9. International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study).
Arnold M; Morgan E; Bardot A; Rutherford MJ; Ferlay J; Little A; Møller B; Bucher O; De P; Woods RR; Saint-Jacques N; Gavin AT; Engholm G; Achiam MP; Porter G; Walsh PM; Vernon S; Kozie S; Ramanakumar AV; Lynch C; Harrison S; Merrett N; O'Connell DL; Mala T; Elwood M; Zalcberg J; Huws DW; Ransom D; Bray F; Soerjomataram I
Gut; 2022 Aug; 71(8):1532-1543. PubMed ID: 34824149
[TBL] [Abstract][Full Text] [Related]
10. International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study.
Araghi M; Fidler-Benaoudia M; Arnold M; Rutherford M; Bardot A; Ferlay J; Bucher O; De P; Engholm G; Gavin A; Kozie S; Little A; Møller B; St Jacques N; Tervonen H; Walsh P; Woods R; O'Connell DL; Baldwin D; Elwood M; Siesling S; Bray F; Soerjomataram I; ; ; ; ;
Thorax; 2022 Apr; 77(4):378-390. PubMed ID: 34282033
[TBL] [Abstract][Full Text] [Related]
11. Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 study.
Cabasag CJ; Arnold M; Rutherford M; Ferlay J; Bardot A; Morgan E; Butler J; O'Connell DL; Nelson G; Høgdall C; Schnack T; Gavin A; Elwood M; Hanna L; Gourley C; De P; Saint-Jacques N; Mørch LS; Woods RR; Altman AD; Sykes P; Cohen PA; McNally O; Møller B; Walsh P; Morrison DS; Bray F; Soerjomataram I
Int J Cancer; 2023 May; 152(9):1763-1777. PubMed ID: 36533660
[TBL] [Abstract][Full Text] [Related]
12. Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007.
Maringe C; Walters S; Rachet B; Butler J; Fields T; Finan P; Maxwell R; Nedrebø B; Påhlman L; Sjövall A; Spigelman A; Engholm G; Gavin A; Gjerstorff ML; Hatcher J; Johannesen TB; Morris E; McGahan CE; Tracey E; Turner D; Richards MA; Coleman MP;
Acta Oncol; 2013 Jun; 52(5):919-32. PubMed ID: 23581611
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study.
McPhail S; Swann R; Johnson SA; Barclay ME; Abd Elkader H; Alvi R; Barisic A; Bucher O; Clark GRC; Creighton N; Danckert B; Denny CA; Donnelly DW; Dowden JJ; Finn N; Fox CR; Fung S; Gavin AT; Gomez Navas E; Habbous S; Han J; Huws DW; Jackson CGCA; Jensen H; Kaposhi B; Kumar SE; Little AL; Lu S; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Te Marvelde L; Thomas RS; Thomas RJS; Thomson CS; Woods RR; Zhang B; Lyratzopoulos G;
Lancet Oncol; 2022 May; 23(5):587-600. PubMed ID: 35397210
[TBL] [Abstract][Full Text] [Related]
14. Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership.
Walters S; Maringe C; Butler J; Brierley JD; Rachet B; Coleman MP
Int J Cancer; 2013 Feb; 132(3):676-85. PubMed ID: 22623157
[TBL] [Abstract][Full Text] [Related]
15. International trends in oesophageal cancer survival by histological subtype between 1995 and 2014.
Morgan E; Soerjomataram I; Gavin AT; Rutherford MJ; Gatenby P; Bardot A; Ferlay J; Bucher O; De P; Engholm G; Jackson C; Kozie S; Little A; Møller B; Shack L; Tervonen H; Thursfield V; Vernon S; Walsh PM; Woods RR; Finley C; Merrett N; O'Connell DL; Reynolds JV; Bray F; Arnold M
Gut; 2021 Feb; 70(2):234-242. PubMed ID: 32554620
[TBL] [Abstract][Full Text] [Related]
16. The impact of reclassifying cancers of unspecified histology on international differences in survival for small cell and non-small cell lung cancer (ICBP SurvMark-2 project).
Morgan E; Arnold M; Rutherford MJ; Bardot A; Ferlay J; De P; Engholm G; Jackson C; Little A; Saint-Jacques N; Walsh P; Woods RR; O'Connell DL; Bray F; Parkin DM; Soerjomataram I
Int J Cancer; 2021 Sep; 149(5):1013-1020. PubMed ID: 33932300
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007.
Walters S; Maringe C; Coleman MP; Peake MD; Butler J; Young N; Bergström S; Hanna L; Jakobsen E; Kölbeck K; Sundstrøm S; Engholm G; Gavin A; Gjerstorff ML; Hatcher J; Johannesen TB; Linklater KM; McGahan CE; Steward J; Tracey E; Turner D; Richards MA; Rachet B;
Thorax; 2013 Jun; 68(6):551-64. PubMed ID: 23399908
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study.
Walters S; Maringe C; Butler J; Rachet B; Barrett-Lee P; Bergh J; Boyages J; Christiansen P; Lee M; Wärnberg F; Allemani C; Engholm G; Fornander T; Gjerstorff ML; Johannesen TB; Lawrence G; McGahan CE; Middleton R; Steward J; Tracey E; Turner D; Richards MA; Coleman MP;
Br J Cancer; 2013 Mar; 108(5):1195-208. PubMed ID: 23449362
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study.
Benitez Majano S; Di Girolamo C; Rachet B; Maringe C; Guren MG; Glimelius B; Iversen LH; Schnell EA; Lundqvist K; Christensen J; Morris M; Coleman MP; Walters S
Lancet Oncol; 2019 Jan; 20(1):74-87. PubMed ID: 30545752
[TBL] [Abstract][Full Text] [Related]
20. Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care.
Norell CH; Butler J; Farrell R; Altman A; Bentley J; Cabasag CJ; Cohen PA; Fegan S; Fung-Kee-Fung M; Gourley C; Hacker NF; Hanna L; Høgdall CK; Kristensen G; Kwon J; McNally O; Nelson G; Nordin A; O'Donnell D; Schnack T; Sykes PH; Zotow E; Harrison S
Int J Gynecol Cancer; 2020 Nov; 30(11):1748-1756. PubMed ID: 32784203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
